Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor infiltrating lymphocytes in early breast cancer
Giancarlo Pruneri, Andrea Vingiani, Carsten Denkert
The Breast (2017) Vol. 37, pp. 207-214
Closed Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
Vincenzo Salemme, Giorgia Centonze, Federica Cavallo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 184
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
Xavier Tekpli, Tonje G. Lien, Andreas Hagen Røssevold, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 161
Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics
Tosin Akinsipe, Rania Mohamedelhassan, Ayuba Akinpelu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
Current State of Dendritic Cell-Based Immunotherapy: Opportunities for in vitro Antigen Loading of Different DC Subsets?
Anne Huber, Floris Dammeijer, Joachim G.J.V. Aerts, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 112
Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art
Cinzia Solinas, Luisa Carbognin, Pushpamali De Silva, et al.
The Breast (2017) Vol. 35, pp. 142-150
Closed Access | Times Cited: 105
Immune Infiltration in Invasive Lobular Breast Cancer
Christine Desmedt, Roberto Salgado, Marco Fornili, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 110, Iss. 7, pp. 768-776
Open Access | Times Cited: 98
Immunotherapy in breast cancer: Current status and future directions
Amrita Basu, Ganesan Ramamoorthi, Yongsheng Jia, et al.
Advances in cancer research (2019), pp. 295-349
Closed Access | Times Cited: 95
The Immune Microenvironment of Breast Cancer Progression
Helen Tower, Meagan Ruppert, Kara L. Britt
Cancers (2019) Vol. 11, Iss. 9, pp. 1375-1375
Open Access | Times Cited: 95
Clinical significance and immunogenomic landscape analyses of the immune cell signature based prognostic model for patients with breast cancer
Shiyuan Wang, Yuqiang Xiong, Qi Zhang, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 4
Closed Access | Times Cited: 92
Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma
John Barrett, Hongliang Cai, John Miao, et al.
Cancer Gene Therapy (2018) Vol. 25, Iss. 5-6, pp. 106-116
Open Access | Times Cited: 87
The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice
Chenchen Li, Yajun Xu, Junfeng Zhang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Establishment of a 3D Co-culture With MDA-MB-231 Breast Cancer Cell Line and Patient-Derived Immune Cells for Application in the Development of Immunotherapies
Diana P. Saraiva, Ana T. Matias, Sofía Braga, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 60
Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer
Arushi Jaiswal, Kiichi Murakami, Andrew Elia, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 38
Open Access | Times Cited: 46
A review concerning the breast cancer-related tumour microenvironment
Oscar Hernán Rodríguez-Bejarano, Carlos Parra-López, Manuel A. Patarroyo
Critical Reviews in Oncology/Hematology (2024) Vol. 199, pp. 104389-104389
Open Access | Times Cited: 7
The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer
François Bertucci, Pascal Finetti, Ines Simeone, et al.
British Journal of Cancer (2018) Vol. 119, Iss. 11, pp. 1383-1391
Open Access | Times Cited: 58
Effect of Radiotherapy After Breast-Conserving Surgery Depending on the Presence of Tumor-Infiltrating Lymphocytes: A Long-Term Follow-Up of the SweBCG91RT Randomized Trial
Anikó Kovács, Axel Stenmark Tullberg, Elisabeth Werner Rönnerman, et al.
Journal of Clinical Oncology (2019) Vol. 37, Iss. 14, pp. 1179-1187
Closed Access | Times Cited: 54
Tumor-Infiltrating CD8 T Cells Predict Clinical Breast Cancer Outcomes in Young Women
Yong Won Jin, Pingzhao Hu
Cancers (2020) Vol. 12, Iss. 5, pp. 1076-1076
Open Access | Times Cited: 43
The breast cancer immune microenvironment is modified by neoadjuvant chemotherapy
Claudia Urueña, Paola Lasso, David Andrés Bernal-Estévez, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer
Melani Luque, Marta Sanz-Álvarez, Miriam Morales-Gallego, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6034-6034
Open Access | Times Cited: 23
Estrogen receptor regulation of the immune microenvironment in breast cancer
Conor McGuinness, Kara L. Britt
The Journal of Steroid Biochemistry and Molecular Biology (2024) Vol. 240, pp. 106517-106517
Closed Access | Times Cited: 5
Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics
Shakila Jabeen, Jaime A. Espinoza, Lilly Anne Torland, et al.
OncoImmunology (2018) Vol. 8, Iss. 2, pp. e1537691-e1537691
Open Access | Times Cited: 41
The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status
Anna Glajcar, Joanna Szpor, Diana Hodorowicz‐Zaniewska, et al.
Virchows Archiv (2019) Vol. 475, Iss. 1, pp. 13-23
Open Access | Times Cited: 40
Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma
Jean‐Christophe Tille, André Filipe Vieira, C. Saint-Martin, et al.
Modern Pathology (2020) Vol. 33, Iss. 11, pp. 2198-2207
Open Access | Times Cited: 34
Optimized tumour infiltrating lymphocyte assessment for triple negative breast cancer prognostics
Maschenka Balkenhol, Francesco Ciompi, Żaneta Świderska-Chadaj, et al.
The Breast (2021) Vol. 56, pp. 78-87
Open Access | Times Cited: 28
Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses
Diana P. Saraiva, Bruna Correia, Rute Salvador, et al.
Oncotarget (2021) Vol. 12, Iss. 24, pp. 2388-2403
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top